Skip to main content
Signal8

DRIEHAUS CAPITAL MANAGEMENT LLC

DRIEHAUS CAPITAL MANAGEMENT LLC is a Mutual Fund institutional filer with the SEC under CIK 938206, reporting 354 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in DRIEHAUS CAPITAL MANAGEMENT LLC's most recent 13F filing, ranked by reported market value.

  1. TSMC (TSM)
  2. Definium Therapeutics Inc (DFTX)
  3. Praxis Precision Medicines Inc (PRAX)
  4. Xenon Pharmaceuticals Inc (XENE)
  5. Silicon Motion Technology Corp (SIMO)
  6. Spyre Therapeutics Inc (SYRE)
  7. Crinetics Pharmaceuticals Inc (CRNX)
  8. Apogee Therapeutics Inc (APGE)
  9. Guardant Health Inc (GH)
  10. Planet Labs PBC (PL)
/